Solventum Corp. (SOLV)
91.31
+1.74
(+1.94%)
USD |
NYSE |
Aug 24, 16:00
91.31
0.00 (0.00%)
After-Hours: 20:00
Solventum Gross Profit Margin (Quarterly) : 58.44% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.44% |
| March 31, 2026 | 54.81% |
| December 31, 2025 | 53.40% |
| September 30, 2025 | 53.91% |
| June 30, 2025 | 63.77% |
| March 31, 2025 | 54.98% |
| December 31, 2024 | 56.22% |
| Date | Value |
|---|---|
| September 30, 2024 | 55.96% |
| June 30, 2024 | 54.64% |
| March 31, 2024 | 58.13% |
| December 31, 2023 | 56.88% |
| September 30, 2023 | 58.29% |
| June 30, 2023 | 57.27% |
| March 31, 2023 | 56.54% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Stryker Corp. | 66.14% |
| Zimmer Biomet Holdings, Inc. | 62.91% |
| Edwards Lifesciences Corp. | 78.09% |
| Intuitive Surgical, Inc. | 67.76% |
| Inspire Medical Systems, Inc. | 85.48% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.58% |
| Return on Assets | 10.00% |
| Return on Invested Capital | 13.73% |
| Profit Margin (Quarterly) | 4.16% |
| Operating Margin (Quarterly) | 9.91% |
| Return on Net Operating Assets | 12.18% |